• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病细胞图谱(TACA):阿尔茨海默病转化治疗加速器的单细胞分子图谱。

The Alzheimer's Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer's disease.

作者信息

Zhou Yadi, Xu Jielin, Hou Yuan, Bekris Lynn, Leverenz James B, Pieper Andrew A, Cummings Jeffrey, Cheng Feixiong

机构信息

Genomic Medicine Institute Lerner Research Institute Cleveland Clinic Cleveland Ohio USA.

Department of Molecular Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University Cleveland Ohio USA.

出版信息

Alzheimers Dement (N Y). 2022 Oct 13;8(1):e12350. doi: 10.1002/trc2.12350. eCollection 2022.

DOI:10.1002/trc2.12350
PMID:36254161
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9558163/
Abstract

INTRODUCTION

Recent advances in generating massive single-cell/nucleus transcriptomic data have shown great potential for facilitating the identification of cell type-specific Alzheimer's disease (AD) pathobiology and drug-target discovery for therapeutic development.

METHODS

We developed The Alzheimer's Cell Atlas (TACA) by compiling an AD brain cell atlas consisting of over 1.1 million cells/nuclei across 26 data sets, covering major brain regions (hippocampus, cerebellum, prefrontal cortex, and so on) and cell types (astrocyte, microglia, neuron, oligodendrocytes, and so on). We conducted nearly 1400 differential expression comparisons to identify cell type-specific molecular alterations (e.g., case vs healthy control, sex-specific, apolipoprotein E () ε4/ε4, and TREM2 mutations). Each comparison was followed by protein-protein interaction module detection, functional enrichment analysis, and omics-informed target and drug (over 700,000 perturbation profiles) screening. Over 400 cell-cell interaction analyses using 6000 ligand-receptor interactions were conducted to identify the cell-cell communication networks in AD.

RESULTS

All results are integrated into TACA (https://taca.lerner.ccf.org/), a new web portal with cell type-specific, abundant transcriptomic information, and 12 interactive visualization tools for AD.

DISCUSSION

We envision that TACA will be a highly valuable resource for both basic and translational research in AD, as it provides abundant information for AD pathobiology and actionable systems biology tools for drug discovery.

HIGHLIGHTS

We compiled an Alzheimer's disease (AD) brain cell atlas consisting of more than 1.1 million cells/nuclei transcriptomes from 26 data sets, covering major brain regions (cortex, hippocampus, cerebellum) and cell types (e.g., neuron, oligodendrocyte, astrocyte, and microglia).We conducted over 1400 differential expression (DE) comparisons to identify cell type-specific gene expression alterations. Major comparison types are (1) AD versus healthy control; (2) sex-specific DE, (3) genotype-driven DE (i.e., apolipoprotein E [] ε4/ε4 vs ε3/ε3; TREM2 vs common variants) analysis; and (4) others. Each comparison was further followed by (1) human protein-protein interactome network module analysis, (2) pathway enrichment analysis, and (3) gene-set enrichment analysis.For drug screening, we conducted gene set enrichment analysis for all the comparisons with over 700,000 drug perturbation profiles connecting more than 10,000 human genes and 13,000 drugs/compounds.A total of over 400 analyses of cell-cell interactions against 6000 experimentally validated ligand-receptor interactions were conducted to reveal the disease-relevant cell-cell communications in AD.

摘要

引言

在生成大规模单细胞/细胞核转录组数据方面的最新进展显示出巨大潜力,有助于识别细胞类型特异性的阿尔茨海默病(AD)病理生物学特征,并发现用于治疗开发的药物靶点。

方法

我们通过汇编一个AD脑细胞图谱开发了阿尔茨海默病细胞图谱(TACA),该图谱包含来自26个数据集的超过110万个细胞/细胞核,覆盖主要脑区(海马体、小脑、前额叶皮层等)和细胞类型(星形胶质细胞、小胶质细胞、神经元、少突胶质细胞等)。我们进行了近1400次差异表达比较,以识别细胞类型特异性的分子改变(例如病例与健康对照、性别特异性、载脂蛋白E(ApoE)ε4/ε4以及TREM2突变)。每次比较后都进行蛋白质-蛋白质相互作用模块检测、功能富集分析以及基于组学的靶点和药物(超过70万个扰动图谱)筛选。使用6000种配体-受体相互作用进行了400多次细胞-细胞相互作用分析,以识别AD中的细胞-细胞通讯网络。

结果

所有结果都整合到TACA(https://taca.lerner.ccf.org/)中,这是一个新的网站门户,具有细胞类型特异性的丰富转录组信息以及12个用于AD的交互式可视化工具。

讨论

我们设想TACA将成为AD基础研究和转化研究的极有价值的资源,因为它为AD病理生物学提供了丰富信息,并为药物发现提供了可操作的系统生物学工具。

要点

我们汇编了一个阿尔茨海默病(AD)脑细胞图谱,该图谱包含来自26个数据集的超过110万个细胞/细胞核转录组,覆盖主要脑区(皮层、海马体、小脑)和细胞类型(例如神经元、少突胶质细胞、星形胶质细胞和小胶质细胞)。我们进行了1400多次差异表达(DE)比较,以识别细胞类型特异性的基因表达改变。主要比较类型包括:(1)AD与健康对照;(2)性别特异性DE;(3)基因型驱动的DE(即载脂蛋白E [ApoE] ε4/ε4与ε3/ε3;TREM2与常见变体)分析;以及(4)其他。每次比较之后还进一步进行了:(1)人类蛋白质-蛋白质相互作用组网络模块分析;(2)通路富集分析;以及(3)基因集富集分析。对于药物筛选,我们对所有比较进行了基因集富集分析,使用了超过70万个连接10000多个人类基因和13000种药物/化合物的药物扰动图谱。针对6000种经过实验验证的配体-受体相互作用,总共进行了400多次细胞-细胞相互作用分析,以揭示AD中与疾病相关的细胞-细胞通讯。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/377193ce1e4b/TRC2-8-e12350-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/143515354eb1/TRC2-8-e12350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/15c5507280cf/TRC2-8-e12350-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/f24d45405213/TRC2-8-e12350-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/6d47be4ba2e5/TRC2-8-e12350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/4696677e5f2f/TRC2-8-e12350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/377193ce1e4b/TRC2-8-e12350-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/143515354eb1/TRC2-8-e12350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/15c5507280cf/TRC2-8-e12350-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/f24d45405213/TRC2-8-e12350-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/6d47be4ba2e5/TRC2-8-e12350-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/4696677e5f2f/TRC2-8-e12350-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0240/9558163/377193ce1e4b/TRC2-8-e12350-g004.jpg

相似文献

1
The Alzheimer's Cell Atlas (TACA): A single-cell molecular map for translational therapeutics accelerator in Alzheimer's disease.阿尔茨海默病细胞图谱(TACA):阿尔茨海默病转化治疗加速器的单细胞分子图谱。
Alzheimers Dement (N Y). 2022 Oct 13;8(1):e12350. doi: 10.1002/trc2.12350. eCollection 2022.
2
AlzGPS: a genome-wide positioning systems platform to catalyze multi-omics for Alzheimer's drug discovery.阿尔茨海默病基因组定位系统(AlzGPS):一个用于促进阿尔茨海默病药物发现的多组学全基因组定位系统平台。
Alzheimers Res Ther. 2021 Jan 13;13(1):24. doi: 10.1186/s13195-020-00760-w.
3
Bioinformatics Analysis of Publicly Available Single-Nuclei Transcriptomics Alzheimer's Disease Datasets Reveals Genotype-Specific Changes Across Cell Types in Two Brain Regions.公开可用的单细胞核转录组学阿尔茨海默病数据集的生物信息学分析揭示了两个脑区不同细胞类型中的基因型特异性变化。
Front Aging Neurosci. 2022 Apr 27;14:749991. doi: 10.3389/fnagi.2022.749991. eCollection 2022.
4
The influence of APOE on the pTau interactome in sporadic Alzheimer's disease.载脂蛋白 E 对散发性阿尔茨海默病中 pTau 相互作用组的影响。
Acta Neuropathol. 2024 May 21;147(1):91. doi: 10.1007/s00401-024-02744-8.
5
Monomeric C-reactive protein induces the cellular pathology of Alzheimer's disease.单体C反应蛋白诱发阿尔茨海默病的细胞病理学变化。
Alzheimers Dement (N Y). 2022 Jul 8;8(1):e12319. doi: 10.1002/trc2.12319. eCollection 2022.
6
Blood and brain transcriptome analysis reveals APOE genotype-mediated and immune-related pathways involved in Alzheimer disease.血液和大脑转录组分析揭示了 APOE 基因型介导的和与免疫相关的阿尔茨海默病通路。
Alzheimers Res Ther. 2022 Feb 9;14(1):30. doi: 10.1186/s13195-022-00975-z.
7
Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.载脂蛋白 E ɛ3 对中国人群散发性阿尔茨海默病的保护作用:荟萃分析。
Sci Rep. 2022 Aug 10;12(1):13620. doi: 10.1038/s41598-022-18033-x.
8
Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.载脂蛋白E基因型与阿尔茨海默病的性别风险因素:一项荟萃分析。
JAMA Neurol. 2017 Oct 1;74(10):1178-1189. doi: 10.1001/jamaneurol.2017.2188.
9
Sex specific molecular networks and key drivers of Alzheimer's disease.性别特异性分子网络与阿尔茨海默病的关键驱动因素。
Mol Neurodegener. 2023 Jun 20;18(1):39. doi: 10.1186/s13024-023-00624-5.
10
Characterizing dysregulations via cell-cell communications in Alzheimer's brains using single-cell transcriptomes.利用单细胞转录组学描绘阿尔茨海默病大脑中的细胞间通讯失调特征。
BMC Neurosci. 2024 May 13;25(1):24. doi: 10.1186/s12868-024-00867-y.

引用本文的文献

1
Protein kinase CK2α' as a dual modulator of neuroimmune signaling and synaptic dysfunction in Tauopathy.蛋白激酶CK2α'作为Tau蛋白病中神经免疫信号和突触功能障碍的双重调节因子。
Res Sq. 2025 Aug 7:rs.3.rs-7078069. doi: 10.21203/rs.3.rs-7078069/v1.
2
Combining xQTL and genome-wide association studies from ethnically diverse populations improves druggable gene discovery.将来自不同种族人群的全基因组关联研究与全基因组转录定量位点分析相结合,可改善可成药基因的发现。
Res Sq. 2025 May 28:rs.3.rs-6700169. doi: 10.21203/rs.3.rs-6700169/v1.
3
Alzheimer's disease knowledge graph enhances knowledge discovery and disease prediction.

本文引用的文献

1
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer's disease.基于表型的计算网络医学发现结合保险记录数据挖掘,鉴定西地那非是治疗阿尔茨海默病的候选药物。
Nat Aging. 2021 Dec;1(12):1175-1188. doi: 10.1038/s43587-021-00138-z. Epub 2021 Dec 6.
2
The Tabula Sapiens: A multiple-organ, single-cell transcriptomic atlas of humans.智慧人图谱:人类多器官单细胞转录组图谱。
Science. 2022 May 13;376(6594):eabl4896. doi: 10.1126/science.abl4896.
3
2022 Alzheimer's disease facts and figures.
阿尔茨海默病知识图谱增强了知识发现和疾病预测能力。
Comput Biol Med. 2025 Apr 29;192(Pt A):110285. doi: 10.1016/j.compbiomed.2025.110285.
4
Drug repurposing for Alzheimer's disease and other neurodegenerative disorders.用于阿尔茨海默病及其他神经退行性疾病的药物重新定位。
Nat Commun. 2025 Feb 19;16(1):1755. doi: 10.1038/s41467-025-56690-4.
5
Utilization of precision medicine digital twins for drug discovery in Alzheimer's disease.利用精准医学数字孪生体进行阿尔茨海默病药物研发。
Neurotherapeutics. 2025 Apr;22(3):e00553. doi: 10.1016/j.neurot.2025.e00553. Epub 2025 Feb 17.
6
A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease.基于网络的系统遗传学框架揭示帕金森病的病理生物学及药物再利用
NPJ Parkinsons Dis. 2025 Jan 22;11(1):22. doi: 10.1038/s41531-025-00870-y.
7
Unraveling Alzheimer's disease: insights from single-cell sequencing and spatial transcriptomic.解析阿尔茨海默病:来自单细胞测序和空间转录组学的见解
Front Neurol. 2024 Dec 17;15:1515981. doi: 10.3389/fneur.2024.1515981. eCollection 2024.
8
Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects.多层组学方法揭示阿尔茨海默病中神经胶质细胞的特异性改变:系统综述与未来展望
Glia. 2025 Mar;73(3):539-573. doi: 10.1002/glia.24652. Epub 2024 Dec 9.
9
Single-microglia transcriptomic transition network-based prediction and real-world patient data validation identifies ketorolac as a repurposable drug for Alzheimer's disease.基于单小胶质细胞转录组转变网络的预测及真实世界患者数据验证,确定酮咯酸为可用于阿尔茨海默病的可重新利用药物。
Alzheimers Dement. 2025 Jan;21(1):e14373. doi: 10.1002/alz.14373. Epub 2024 Dec 6.
10
A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson's disease.一种基于网络的系统遗传学框架识别帕金森病中的病理生物学和药物再利用。
Res Sq. 2024 Oct 14:rs.3.rs-4869009. doi: 10.21203/rs.3.rs-4869009/v1.
2022 年阿尔茨海默病事实和数据。
Alzheimers Dement. 2022 Apr;18(4):700-789. doi: 10.1002/alz.12638. Epub 2022 Mar 14.
4
Artificial intelligence framework identifies candidate targets for drug repurposing in Alzheimer's disease.人工智能框架识别阿尔茨海默病药物再利用的候选靶点。
Alzheimers Res Ther. 2022 Jan 10;14(1):7. doi: 10.1186/s13195-021-00951-z.
5
Autophagy in healthy aging and disease.自噬在健康衰老和疾病中的作用。
Nat Aging. 2021 Aug;1(8):634-650. doi: 10.1038/s43587-021-00098-4. Epub 2021 Aug 12.
6
Single-nucleus chromatin accessibility and transcriptomic characterization of Alzheimer's disease.阿尔茨海默病中单细胞核染色质可及性和转录组特征。
Nat Genet. 2021 Aug;53(8):1143-1155. doi: 10.1038/s41588-021-00894-z. Epub 2021 Jul 8.
7
Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer's disease screening and staging.大规模血浆蛋白质组学分析鉴定出用于阿尔茨海默病筛查和分期的高性能生物标志物组合。
Alzheimers Dement. 2022 Jan;18(1):88-102. doi: 10.1002/alz.12369. Epub 2021 May 25.
8
Multimodal single-cell/nucleus RNA sequencing data analysis uncovers molecular networks between disease-associated microglia and astrocytes with implications for drug repurposing in Alzheimer's disease.多模态单细胞/核 RNA 测序数据分析揭示了与疾病相关的小胶质细胞和星形胶质细胞之间的分子网络,这对阿尔茨海默病药物再利用具有启示意义。
Genome Res. 2021 Oct;31(10):1900-1912. doi: 10.1101/gr.272484.120. Epub 2021 Feb 24.
9
Re-emphasizing early Alzheimer's disease pathology starting in select entorhinal neurons, with a special focus on mitophagy.重新强调早期阿尔茨海默病病理学始于特定的内嗅神经元,并特别关注线粒体自噬。
Ageing Res Rev. 2021 May;67:101307. doi: 10.1016/j.arr.2021.101307. Epub 2021 Feb 20.
10
Distinct amyloid-β and tau-associated microglia profiles in Alzheimer's disease.阿尔茨海默病中 distinct amyloid-β 和 tau 相关的小胶质细胞特征。
Acta Neuropathol. 2021 May;141(5):681-696. doi: 10.1007/s00401-021-02263-w. Epub 2021 Feb 20.